U.S. Pharmacist

Advertisement
Advertisement

Cancer Trends in Women

Somnath Pal, BS (Pharm), MBA, PhD
Professor of Pharmacy Administration
College of Pharmacy & Allied Health Professions
St. John's University
Jamaica, New York



9/21/2009
US Pharm. 2009;34(9):10. 

Women are living an average of 79.8 years, which is 5 years longer than the life expectancy for men. However, women are prone to a greater number of diseases during their lifetime. Women have a greater than 1 in 3 lifetime risk of developing cancer.

Incidence: It is estimated that, by the end of 2009, 123.8 per 100,000 women will be diagnosed with breast cancer. Additionally, 103,350 women will be diagnosed with lung or bronchial cancer; 71,380 will be diagnosed with colorectal cancer; 33,860 will be diagnosed with lymphoma; and 31,690 will be diagnosed with skin cancer. It is estimated, moreover, that 22,330 women will be diagnosed with renal cancer; 21,550 will be diagnosed with ovarian cancer; 21,420 will be diagnosed with pancreatic cancer; 19,160 will be diagnosed with leukemia; and 11,270 women will be diagnosed with cervical cancer. 

Survival: The 5-year relative survival rate (RSR) for skin cancer is 93.7% in white women and 91.1% in black women; that for breast cancer is 90% and 78% in white women and black women, respectively. In white women and black women, respectively, RSRs for lymphoma are 72.6% and 68.6%; cervical cancer, 72% and 61.4%; renal cancer, 69.1% and 67.4%; and colorectal cancer, 65.9% and 56.7%. Respective RSRs for leukemia are 53% in white women and 46% in black women; ovarian cancer, 45.8% in white women and 37.4% in black women; and lung or bronchial cancer, 18.3% in white women and 14.5% in black women. Finally, the RSR for pancreatic cancer is 5.5% in white women and 6.2% in black women. 

Lifetime Risk: The probability that a woman will develop breast cancer between her 50th and 70th birthdays is 5.57%; the probability of developing lung or bronchial cancer is 2.29%. Probabilities are 1.54% for colorectal cancer; 0.58% for ovarian cancer; 0.44% for renal cancer; 0.39% for pancreatic cancer; 0.29% for leukemia; and 0.26% for cervical cancer. 

Prevalence: On January 1, 2006, 2.53 million women currently living had a history of breast cancer; 567,158 women had a history of colorectal cancer; 248,166 women had a history of cervical cancer; and 176,007 women had a history of ovarian cancer. In addition, 193,474 women had a history of lung or bronchial cancer; 109,902 women had a history of renal cancer; 101,110 had a history of leukemia; and 16,201 women had a history of pancreatic cancer. 

To comment on this article, contactrdavidson@jobson.com.
Advertisement

U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2013 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.